Risk factors of short-term, intermediate-term, and long-term cardiac events in patients hospitalized for HFmrEF.

Yunlong Zhu,Xin Peng,Mingxin Wu,Haobo Huang,Na Li,Yongliang Chen,Sha Xiao,Hui Zhang,Yuying Zhou,Sihao Chen,Zhican Liu,Liqing Yi,Yiqun Peng,Jie Fan,Jianping Zeng

ESC heart failure（2022）

引用 3|浏览8

暂无评分

摘要

Higher uric acid, creatinine, NT-proBNP, and lower haemoglobin levels at baseline are valuable serum biomarkers for risk stratification of short-term and long-term CV outcomes of HFmrEF patients. Future studies are needed to verify if intensive heart failure therapy for identified high-risk HFmrEF patients based on these four serum biomarkers could improve their short-term and long-term CV outcomes or not.

查看译文

关键词

CV events,HFmrEF,biomarkers,outcome,risk factors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要